Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy
- 20 November 2010
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 148 (1), 75-82
- https://doi.org/10.1016/j.jconrel.2010.06.027
Abstract
For effective cancer gene therapy, systemic administration of tumor-targeting adenoviral (Ad) complexes is critical for delivery to both primary and metastatic lesions. Electrospinning was used to generate nanocomplexes of Ad, chitosan, poly(ethylene glycol) (PEG), and folic acid (FA) for effective FA receptor-expressing tumor-specific transduction. The chemical structure of the Ad/chitosan-PEG-FA nanocomplexes was characterized by NMR and FT-IR, and the diameter and surface charge were analyzed by dynamic light scattering and zeta potentiometry, respectively. The average size of Ad/chitosan-PEG-FA nanocomplexes was approximately 140 nm, and the surface charge was 2.1 mV compared to -4.9 mV for naked Ad. Electron microscopy showed well-dispersed, individual Ad nanocomplexes without aggregation or degradation. Ad/chitosan nanocomplexes retained biological activity without impairment of the transduction efficiency of naked Ad. The transduction efficiency of Ad/chitosan-PEG-FA was increased as a function of FA ratio in FA receptor-expressing KB cells, but not in FA receptor-negative U343 cells, demonstrating FA receptor-targeted viral transduction. In addition, the transduction efficiency of Ad/chitosan-PEG-FA was 57.2% higher than chitosan-encapsulated Ad (Ad/chitosan), showing the superiority of FA receptor-mediated endocytosis for viral transduction. The production of inflammatory cytokine, IL-6 from macrophages was significantly reduced by Ad/chitosan-PEG-FA nanocomplexes, implying the potential for use in systemic administration. These results clearly demonstrate that cancer cell-targeted viral transduction by Ad/chitosan-PEG-FA nanocomplexes can be used effectively for metastatic tumor treatment with reduced immune reaction against Ad.Keywords
Funding Information
- Ministry of Knowledge Economy (10030051)
- Engineering Foundation (R15-2004-024-02001-0)
- Yonsei University College of Medicine. Yeonah Park and Oh-Joon Kwon (6-2010-0052)
This publication has 30 references indexed in Scilit:
- HPMA copolymers for masking and retargeting of therapeutic viruses☆Advanced Drug Delivery Reviews, 2010
- Confined Assembly of Asymmetric Block‐Copolymer Nanofibers via Multiaxial Jet ElectrospinningSmall, 2009
- Chemical Modification with High Molecular Weight Polyethylene Glycol Reduces Transduction of Hepatocytes and Increases Efficacy of Intravenously Delivered Oncolytic AdenovirusHuman Gene Therapy, 2009
- Gene transfer using liposome-complexed adenovirus seems to overcome limitations due to coxsackievirus and adenovirus receptor-deficiency of cancer cells, both in vitro and in vivoExperimental & Molecular Medicine, 2008
- Retargeting of adenoviral gene delivery via Herceptin–PEG–adenovirus conjugates to breast cancer cellsJournal of Controlled Release, 2007
- Relaxin Expression From Tumor-Targeting Adenoviruses and Its Intratumoral Spread, Apoptosis Induction, and EfficacyJNCI Journal of the National Cancer Institute, 2006
- Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancerGene Therapy, 2006
- Adenovirus-Mediated and Targeted Expression of the Sodium–Iodide Symporter PermitsIn VivoRadioiodide Imaging and Therapy of Pancreatic TumorsHuman Gene Therapy, 2006
- Specific Antitumor Targetable β-Cyclodextrin−Poly(ethylene Glycol)−Folic Acid Drug Delivery BioconjugateBioconjugate Chemistry, 2004
- The Use of Field Emission Scanning Electron Microscopy to Assess Recombinant Adenovirus StabilityHuman Gene Therapy, 2002